what are other glp-1 drugs Costs Explained: Managing Coverage Challenges GLP-1 Medications for Weight Loss:

Metabolic liver disease Real-world registry data from Sweden, Denmark, and Norway (20072020) showed a reduced incidence of acute liver events in individuals with type 2 diabetes initiating GLP-1RA therapy compared to dipeptidyl peptidase 4 (DPP-4) inhibitors

Baisley and Baldo, 2014

Conclusion: The Future of Metabolic Health is Green The rising tide of metabolic health concerns, coupled with a growing consumer desire for natural and preventive solutions, positions natural GLP-1 promoters at the forefront of innovative wellness strategies

They are usually responding to a specific gap in your control or your risk profile

Weight management/metabolic effects: GLP-1 RAs may also support weight management in adults with type 2 diabetes who are overweight or obese, providing an added metabolic advantage alongside their primary glycaemic and cardioprotective effects